CD4 (W3/25) Antibody sc-20079 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCD4 (W3/25) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-20079
Antibody TypePrimary Antibodies
CloneW3/25
Quantity200 µg/ml
ApplicationsIF, IHC(P), FCM
Reactivitymouse, rat
Hostmouse
ClonalityMonoclonal
FormatPurified
Conjugate/TagUnconjugated
TargetCD4
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed PatientsCellsAugust 28, 2024Junyue Zhang, Yiping Song, Ae-Ri Ahn, Ho Sung Park, See-Hyoung Park, Young Jae Moon, Kyoung Min Kim, Kyu Yun JangCell Signaling Technology, Beverly, MA, USA), FoxP3 (#126402, 1:200, BioLegend, San Diego, CA, USA), CD4 (#sc20079, 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and CD8 (#sc-18860, 1:100, Santa Cruz Biotechnology,

(2) Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytesBMC cancerJanuary 13, 2023Shao S, Scholtz LU, Gendreizig S, Martínez-Ruiz L, Florido J, Escames G, Schürmann M, Hain C, Hose L, Mentz A, et al.

(3) Orthotopic and heterotopic triple negative breast cancer preclinical murine models: A tumor microenvironment comparativeResearch in veterinary scienceDecember 20, 2022Santana-Krímskaya SE, Kawas JR, Zarate-Triviño DG, Ramos-Zayas Y, Rodríguez-Padilla C, Franco-Molina MA.

(4) The Combination of Rhodosin and MMF Prolongs Cardiac Allograft Survival by Inhibiting DC Maturation by Promoting Mitochondrial FusionOxidative medicine and cellular longevityJanuary 1, 2022Che Y, Chen Y, Wang Z, Zheng S, Xing K, Yuan S, Zhong X.5% goat serum (Beyotime Bio, #C0265, China), and then incubated with anti-CD4 (1 : 100, Santa Cruz, #sc-20079, China) and anti-CD8 (1 : 100, Santa Cruz, #sc-1177, China) overnight at 4°C. The next day, the sections

(5) Imbalanced T-Cell Subsets May Facilitate the Occurrence of Osteonecrosis of the Femoral HeadJournal of inflammation researchJanuary 1, 2022Chen C, Zhao X, Luo Y, Li B, Li Q, Zhao C, Huang Y, Kang P.Animals. Immunofluorescence Assay The tissue sections were treated with 1:50 dilutions of mouse anti‐CD4 (cat. no. Sc-20079; Santa Cruz Biotechnology Inc., Dallas, TX, USA), mouse anti-RANKL (cat. no. sc-377079; Santa Cruz Biotechnology Inc

(6) Knockdown of miR‑205‑5p alleviates the inflammatory response in allergic rhinitis by targeting B‑cell lymphoma 6Molecular medicine reportsNovember 1, 2021Zhang S, Lin S, Tang Q, Yan Z.Bs-2734R; Beijing Biosynthesis Biotechnology Co., Ltd.) and monoclonal anti-CD4 (dilution, 1:50; cat. no. Sc-20079; Santa Cruz Biotechnology, Inc.) or anti-F4/80 (dilution, 1:50; cat. no. Sc-377009; Santa Cruz Biotechnology, Inc

(7) Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 BalanceFrontiers in pharmacologyJanuary 1, 2019Zhao X, Liu J, Ge S, Chen C, Li S, Wu X, Feng X, Wang Y, Cai D.

(8) Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat modelAmerican journal of physiology. Renal physiologyJuly 15, 2013Guan Q, Li S, Gao S, Chen H, Nguan CY, Du C.

(9) Lipopolysaccharide (LPS) induced activation of the immune system in control rats and rats chronically exposed to a low level of the organothiophosphate insecticide, acephateToxicology and industrial healthJuly 1, 2003Singh AK, Jiang Y.

Be the First to Write a Review!

CD4 (W3/25) Antibody

CD4 (W3/25) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (9)

Reviews

CD4 (W3/25) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map